SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.
SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.
复制标题
SH3BP2天使突变通过NFATC1和TNF-α介导的炎症性骨质流失增强了TNF-α诱导的破骨细胞生成。
DOI:
10.1002/jbmr.2295
复制
发表时间:
2014-12
影响因子:
6.2
通讯作者:
Ueki, Yasuyoshi
中科院分区:
文献类型:
--
作者:
Mukai, Tomoyuki;Ishida, Shu;Ishikawa, Remi;Yoshitaka, Teruhito;Kittaka, Mizuho;Gallant, Richard;Lin, Yi-Ling;Rottapel, Robert;Brotto, Marco;Reichenberger, Ernst J.;Ueki, Yasuyoshi
Cherubism (OMIM#118400) is a genetic disorder with excessive jawbone resorption caused by mutations in the signaling adaptor protein SH3BP2. Studies on the mouse model for cherubism carrying a P416R knock-in mutation have revealed that mutant SH3BP2 enhances TNF-α production and RANKL-induced osteoclast differentiation in myeloid cells. TNF-α is expressed in human cherubism lesions, which contain a large number of TRAP-positive multinucleated cells, and TNF-α plays a critical role in inflammatory bone destruction in homozygous cherubism mice (Sh3bp2KI/KI). The data suggest a pathophysiological relationship between mutant SH3BP2 and TNF-α-mediated bone loss by osteoclasts. Therefore, we investigated whether P416R mutant SH3BP2 is involved in TNF-α-mediated osteoclast formation and bone loss. Here, we show that bone marrow-derived M-CSF-dependent macrophages (BMMs) from the heterozygous cherubism mutant (Sh3bp2KI/+) mice are highly responsive to TNF-α and can differentiate into osteoclasts independently of RANKL in vitro by a mechanism that involves SYK and PLCγ2 phosphorylation, leading to increased nuclear translocation of NFATc1. The heterozygous cherubism mutation exacerbates bone loss with increased osteoclast formation in a mouse calvarial TNF-α injection model as well as in a human TNF-α transgenic mouse model (hTNFtg). SH3BP2 knockdown in RAW264.7 cells results in decreased TRAP-positive multinucleated cell formation. These findings suggest that the SH3BP2 cherubism mutation can cause jawbone destruction by promoting osteoclast formation in response to TNF-α expressed in cherubism lesions and that SH3BP2 is a key regulator for TNF-α-induced osteoclastogenesis. Inhibition of SH3BP2 expression in osteoclast progenitors could be a potential strategy for the treatment of bone loss in cherubism as well as in other inflammatory bone disorders.
登录
查看更多内容
影响因子:
--
作者:
Hayward, Michael D;Jones, Beverly K;Saparov, Arman;Hain, Heather S;Trillat, Anne-Cecile;Bunzel, Michelle M;Corona, Aaron;Li-Wang, Bifang;Strenkowski, Bryan;Giordano, Caroline;Shen, Hai;Arcamone, Emily;Weidlick, Jeffrey;Vilensky, Maria;Tugusheva, Marina;Felkner, Roland H;Campbell, William;Rao, Yu;Grass, David S;Buiakova, Olesia
通讯作者:
Buiakova, Olesia
影响因子:
4
作者:
Faccio, R;Zou, W;Ross, FP
通讯作者:
Ross, FP
影响因子:
3.7
作者:
Chihara, Kazuyasu;Kimura, Yukihiro;Sada, Kiyonao
通讯作者:
Sada, Kiyonao
影响因子:
15.3
作者:
Asagiri, M;Sato, K;Takayanagi, H
通讯作者:
Takayanagi, H
影响因子:
15.3
作者:
Kim, N;Kadono, Y;Choi, Y
通讯作者:
Choi, Y